Bioter S.A. (ATH:BIOT)
Greece flag Greece · Delayed Price · Currency is EUR
0.2060
0.00 (0.00%)
At close: May 30, 2025

Bioter Statistics

Total Valuation

Bioter has a market cap or net worth of EUR 3.45 million. The enterprise value is 192.75 million.

Market Cap3.45M
Enterprise Value 192.75M

Important Dates

The next estimated earnings date is Monday, December 28, 2026.

Earnings Date Dec 28, 2026
Ex-Dividend Date n/a

Share Statistics

Bioter has 16.73 million shares outstanding. The number of shares has decreased by -2.56% in one year.

Current Share Class 16.73M
Shares Outstanding 16.73M
Shares Change (YoY) -2.56%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 46.23%
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.11
PB Ratio -0.04
P/TBV Ratio n/a
P/FCF Ratio 6.01
P/OCF Ratio 6.01
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 335.80

Financial Position

The company has a current ratio of 0.16

Current Ratio 0.16
Quick Ratio 0.16
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 223.79
Interest Coverage -1,090.18

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -73.43%
Return on Invested Capital (ROIC) -99.57%
Return on Capital Employed (ROCE) 74.16%
Weighted Average Cost of Capital (WACC) 0.14%
Revenue Per Employee 106,250
Profits Per Employee -2.29M
Employee Count4
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -1.14M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.90% in the last 52 weeks. The beta is -0.08, so Bioter's price volatility has been lower than the market average.

Beta (5Y) -0.08
52-Week Price Change -25.90%
50-Day Moving Average 0.21
200-Day Moving Average 0.25
Relative Strength Index (RSI) 49.59
Average Volume (20 Days) 6,557

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Bioter had revenue of EUR 425,000 and -9.16 million in losses. Loss per share was -0.56.

Revenue425,000
Gross Profit 162,000
Operating Income -66.50M
Pretax Income -10.30M
Net Income -9.16M
EBITDA -66.39M
EBIT -66.50M
Loss Per Share -0.56
Full Income Statement

Balance Sheet

The company has 617,000 in cash and 128.46 million in debt, with a net cash position of -127.84 million or -7.64 per share.

Cash & Cash Equivalents 617,000
Total Debt 128.46M
Net Cash -127.84M
Net Cash Per Share -7.64
Equity (Book Value) -93.37M
Book Value Per Share -5.94
Working Capital -116.50M
Full Balance Sheet

Cash Flow

Operating Cash Flow 574,000
Capital Expenditures n/a
Depreciation & Amortization 108,000
Net Borrowing -5.39M
Free Cash Flow 574,000
FCF Per Share 0.03
Full Cash Flow Statement

Margins

Gross Margin 38.12%
Operating Margin -15,647.29%
Pretax Margin -2,422.82%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin 135.06%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 54.82%.

Dividend Per Share 0.11
Dividend Yield 54.82%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 2.56%
Shareholder Yield 57.38%
Earnings Yield -265.57%
FCF Yield 16.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 9, 2010. It was a reverse split with a ratio of 0.25.

Last Split Date Aug 9, 2010
Split Type Reverse
Split Ratio 0.25

Scores

Altman Z-Score n/a
Piotroski F-Score 3